Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Workflow of the active inhibition using luteolin and ferulic acid in GBM and other neurodiseases and the future prospects (Created with Adobe Illustrator and BioRender.com).

More »

Fig 1 Expand

Fig 2.

Molecular docking of 5H08 (PTPRZ) + (Luteolin + Ferulic acid); Ramachandran plots at left panel and the 2-D interaction diagram on right panel.

More »

Fig 2 Expand

Table 1.

A list of 10 phytocompounds.

More »

Table 1 Expand

Fig 3.

(a) RMSD of 5H08 (PTPRZ) + (Luteolin + Ferulic acid) after 100 ns run; (b) RMSF of 5H08 (PTPRZ) + (Luteolin + Ferulic acid) after 100 ns run; (c) Radius of Gyration of 5H08 (PTPRZ) + (Luteolin + Ferulic acid) after 100 ns run; (d) Hydrogen bonding of 5H08 (PTPRZ) + (Luteolin + Ferulic acid) after 100 ns run.

More »

Fig 3 Expand

Fig 4.

Types of bonds formed in 5H08 (PTPRZ) + (Luteolin + Ferulic acid) complex and contacts100 ns run.

More »

Fig 4 Expand

Fig 5.

Torsion profiles of luteolin & ferulic acid after 100 ns run.

More »

Fig 5 Expand